Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other 13Gastrointestinal 12Lymphoid 3Thoracic 2Other hematologic neoplasm 2Head & Neck 2Gynecologic 2Genitourinary 2Endocrine 2Dermatologic 2Classical hematology 2Breast 2Other solid neoplasm 1Myeloid 1

Conditions

Lung Neoplasms 1370Carcinoma, Non-Small-Cell Lung 1080Breast Neoplasms 183Neoplasms 145Small Cell Lung Carcinoma 137Colorectal Neoplasms 104Adenocarcinoma of Lung 86Melanoma 84Prostatic Neoplasms 80Pancreatic Neoplasms 79Esophageal Neoplasms 70Head and Neck Neoplasms 69Ovarian Neoplasms 67Colonic Neoplasms 67Stomach Neoplasms 63Urinary Bladder Neoplasms 49Neoplasm Metastasis 49Disease 49Mesothelioma 44Liver Neoplasms 44Pulmonary Disease, Chronic Obstructive 42Mesothelioma, Malignant 42Brain Neoplasms 37Lung Diseases 36Carcinoma, Renal Cell 35Uterine Cervical Neoplasms 34Pleural Effusion, Malignant 34Kidney Neoplasms 33NSCLC 31Carcinoma 28

Interventions

Sulfonylurea Compounds 1Sodium-Glucose Transporter 2 Inhibitors 1Dipeptidyl-Peptidase IV Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Diabetes Mellitus, Type 2 × Thoracic × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT00782366 2011-04-27

PGT

Mayo Clinic

Completed
26 enrolled
BreastGastrointestinalGenitourinaryOtherThoracic

Atrial Fibrillation, Breast Neoplasms, Celiac Disease, Colonic Neoplasms, Diabetes Mellitus, Type 2, Graves Disease, Lung Neoplasms, Myocardial Infarction, Obesity, Osteoarthritis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡